Over the past decade, miRNAs have emerged as genetic factors that can influence immune functions. 1 They act by post-transcriptionally downregulating gene expression either by degrading target mRNAs or by repressing their translation. 2 Linking miRNA expression to disease was first accomplished by comparing outcomes in normal animals with those in miR-155 knockout animals. 3 Our group also used a viral pathogen to show that knocking out miR-155 resulted in less severe inflammatory lesions caused by herpes simplex virus infection, yet animals without miR-155 became more susceptible to developing viral encephalitis. 4, 5 With infectious agents, miRNAs from the agent itself can also influence the outcome of events following infection. 6 For example, herpes viruses express many miRNAs, and these, along with several host miRNAs, may influence the type of interaction the virus has with the host. 6 These interactions can result in a productive infection, persistence in the form of latency, or, in the case of some herpes viruses, neoplasia. 6 MiRNAs may also influence the nature of the inflammatory response to infectious agents that affect, for example, the functional type of lipid mediators produced. 7 There have been many mechanistic studies to determine how various miRNAs influence individual immune components that react to infectious agents, 1 but the present report of Moffett et al. 8 adds an additional chapter to the story. The authors demonstrate that miR-31 production could be a key event in the expression of the immune exhaustion phenotype.
Immune exhaustion has attracted much attention as it appears to explain the failure of the T-cell system to control some cancers and chronic infections. 9 As the American public has learned from TV, immune exhaustion can be reversed, and some cancers can now be controlled with commercially available monoclonal antibodies. 10 The immune exhaustion concept, as it applies to chronic infections, was first noted by Zinkernagel 11 but was popularized by extensive studies of chronic lymphocytic meningitis virus (LCMV), mainly by the Ahmed laboratory. 12, 13 The present communication utilizes Ahmed's LCMV system and makes the novel observation that miR-31 could be responsible for causing the exhaustion phenotype. Such studies may open an additional avenue for pursuing the therapeutic management of exhaustion during chronic infections.
In the Moffett report, T-cell receptor (TCR) and CD28 co-stimulation of naive CD8 T cells was shown to induce the expression of miR-31, a process requiring calcium signaling and subsequent NFAT binding to the locus that encodes miR-31. Moreover, miR-31 production was sustained if the cells were stimulated with cytokines (IL-2 and IL-7), but the same cytokines could not induce miR-31 in naive CD8 T cells. These data clearly indicate that the TCR and downstream signaling stimulate the expression of miR-31 in CD8 T cells. To understand the in vivo consequences of producing miR-31, the effects of knocking out the miR-31 gene globally or specifically in T cells were evaluated in mice subsequently challenged with viral infections. To the authors' disappointment, the outcome of acute infections with LCMV and influenza in knockout and wild-type (WT) animals was basically unchanged. The animals controlled the virus in much the same way and generated similar levels of immunity. However, to the authors' delight, the responses of normal and knockout animals to chronic LCMV infection were considerably different. As previously observed by many groups, WT mice exhibited signs of chronic disease and wasting when infected with LCMV clone 13, 9,13 but the pattern of responsiveness in the knockout animals was quite different. The knockouts had a better CD8 T-cell response in the blood and lymphoid organs and a phenotype that showed less evidence of exhaustion. They demonstrated that the CD8 T-cell population from the miR-31 − / − mice had far fewer cells that expressed PD1, Mt1, Mt2 and Ptger2 (molecules that contribute to CD8 T-cell dysfunction) and higher levels of effector molecules, such as granzyme B, perforin, interferon gamma and tumor necrosis factor alpha. Additionally, the knockout animals were better able to control the infection as their virus levels were significantly decreased in the blood and various tissue samples compared with those in WT animals. Moffett et al. reported that knocking out miR-31 precluded the development of the exhaustion phenotype, which hampers virus control in chronic infections in intact animals. Such data make one wonder why we produce miR-31 as it seems to increase the hazards of chronic infections, an issue that was not addressed.
The observation that miR-31 expression could influence the functional competence of CD8 T-cell immunity prompted further attempts to explain the outcome. Initially, transcriptional profiling was done. In comparing the gene expression of resting transgenic OT-1 CD8 T cells with the same cells induced to overexpress miR-31 via a lentiviral vector system, several differences were observed. Curiously, genes that affected the type 1 interferon system stood out. Thus, miR-31 overexpressing cells had increased expression of Ifna2, Irf3 and Irf7, which are involved in interferon signaling. Moreover, the same cells had reduced expression of 68 miR-31 target genes, which included Ppp6c; Ppp6c has been shown by additional studies to be a relevant mediator that downregulates interferon signaling effects. When Ppp6c was knocked down using a shRNA approach in miR-31 − / − CD8 T cells, the levels of interferon responsiveness were restored to normal levels when exposed to interferon beta. Taken together, these observations indicated that miR-31 targets genes such as Ppp6c in normal cells, which in turn increases the responsiveness to type 1 signaling and thus leads to the exhaustion phenotype (see Figure 1) . The Moffett et al. findings emphasize that exhaustion is the consequence of miR-31 production acting primarily via its effects on interferon signaling. Their report also adds support to previous findings on exhaustion in chronic LCMV infections that proposed that the exhaustion effect was the consequence of continuous exposure to type 1 interferons. 14 What can we take home from these novel observations by Moffett and colleagues? First, the expression of miR--31, which occurs when CD8 T cells are chronically stimulated, is a critical event that seems to explain the resultant loss of function and failure to control a chronic infectious disease. Conceivably, their observations could also imply that downregulating the expression of miR-31 in already exhausted cells might represent a useful approach for treating chronic infection and might also increase the control of some cancers. Although these issues were not studied in the Moffett report, they are well worth following up. Thus, it is possible that counteracting miR-31 activity could provide an alternative approach to current checkpoint inhibitor therapy and might have fewer side effects, such as causing patients to become more susceptible to other infections. It will certainly be interesting to see side-by-side comparisons of anti-miR-31 treatment with one or more of the checkpoint inhibitor cocktails currently being used to treat cancers and chronic infections. miR-31 and CD8 T cell exhaustion S Bhela and BT Rouse
